We thank members of Brain Metastasis Group for critical discussion. Research in the Brain Metastasis Group is supported by MINECO-Retos SAF2017-89643-R (M.V.), Cancer Research Institute CLIP Award 2018 (M.V.), AECC (GCTRA16015SEOA) (M.V.), Bristol-Myers Squibb Melanoma Research Alliance Young Investigator Award 2017 (M.V.), Beug Foundation’s Prize for Metastasis Research 2017 (M.V.), Worldwide Cancer Research (19-0177) (M.V.), H2020-FETOPEN (828972) (M.V.), Fundación Ramón Areces (CIVP19S8163), and La Caixa-Severo Ochoa International PhD Program Fellowship (L.Z.). M.V. is a Ramón y Cajal Investigator (RYC-2013-13365) and an EMBO YIP investigator.N
Brain metastasis (BM) is the commonest form of intracranial malignancy, historically considered a si...
Advances in chemotherapy and targeted therapies have improved survival in cancer patients with an in...
Background Breast cancer is a common cause of brain metastasis. Although breast cancer has relativel...
The microenvironment has emerged as a promising source of novel therapeutic applications in experime...
Brain metastasis, which commonly arises in patients with lung cancer, breast cancer and melanoma, is...
Spread of cancer to the brain remains an unmet clinical need in spite of the increasing number of ca...
Spread of cancer to the brain remains an unmet clinical need in spite of the increasing number of ca...
Brain metastasis is emerging as a unique entity in oncology based on its particular biology and, con...
Brain metastasis, the secondary growth of malignant cells within the central nervous system (CNS), e...
Currently, survival of breast cancer patients with brain metastasis ranges from 2 to 16 months. In e...
Local infiltration and distal dissemination of tumor cells hamper efficacy of current treatments aga...
We report a medium-throughput drug-screening platform (METPlatform) based on organotypic cultures th...
Brain metastases occur in 20-40% of patients with advanced malignancies and lung cancer is one of th...
Brain metastases are the most common malignancy encountered in the central nervous system (CNS), wit...
An estimated 20% of all patients with cancer will develop brain metastases, with the majority of bra...
Brain metastasis (BM) is the commonest form of intracranial malignancy, historically considered a si...
Advances in chemotherapy and targeted therapies have improved survival in cancer patients with an in...
Background Breast cancer is a common cause of brain metastasis. Although breast cancer has relativel...
The microenvironment has emerged as a promising source of novel therapeutic applications in experime...
Brain metastasis, which commonly arises in patients with lung cancer, breast cancer and melanoma, is...
Spread of cancer to the brain remains an unmet clinical need in spite of the increasing number of ca...
Spread of cancer to the brain remains an unmet clinical need in spite of the increasing number of ca...
Brain metastasis is emerging as a unique entity in oncology based on its particular biology and, con...
Brain metastasis, the secondary growth of malignant cells within the central nervous system (CNS), e...
Currently, survival of breast cancer patients with brain metastasis ranges from 2 to 16 months. In e...
Local infiltration and distal dissemination of tumor cells hamper efficacy of current treatments aga...
We report a medium-throughput drug-screening platform (METPlatform) based on organotypic cultures th...
Brain metastases occur in 20-40% of patients with advanced malignancies and lung cancer is one of th...
Brain metastases are the most common malignancy encountered in the central nervous system (CNS), wit...
An estimated 20% of all patients with cancer will develop brain metastases, with the majority of bra...
Brain metastasis (BM) is the commonest form of intracranial malignancy, historically considered a si...
Advances in chemotherapy and targeted therapies have improved survival in cancer patients with an in...
Background Breast cancer is a common cause of brain metastasis. Although breast cancer has relativel...